BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36173444)

  • 1. Phantom smells: a prevalent COVID-19 symptom that progressively sets in.
    Bousquet C; Bouchoucha K; Bensafi M; Ferdenzi C
    Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1219-1229. PubMed ID: 36173444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phantosmia May Predict Long-Term Measurable Olfactory Dysfunction After COVID-19.
    Leung JS; Cordano VP; Fuentes-López E; Lagos AE; García-Huidobro FG; Aliaga R; Díaz LA; García-Salum T; Salinas E; Toro A; Callejas CA; Riquelme A; Palmer JN; Medina RA; González G C
    Laryngoscope; 2022 Dec; 132(12):2445-2452. PubMed ID: 36149773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study.
    Ferdenzi C; Bousquet C; Aguera PE; Dantec M; Daudé C; Fornoni L; Fournel A; Kassan A; Mantel M; Moranges M; Moussy E; Richard Ortegón S; Rouby C; Bensafi M
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34097726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giving a Voice to Patients With Smell Disorders Associated With COVID-19: Cross-Sectional Longitudinal Analysis Using Natural Language Processing of Self-Reports.
    Menger NS; Tognetti A; Farruggia MC; Mucignat C; Bhutani S; Cooper KW; Rohlfs Domínguez P; Heinbockel T; Shields VDC; D'Errico A; Pereda-Loth V; Pierron D; Koyama S; Croijmans I
    JMIR Public Health Surveill; 2024 May; 10():e47064. PubMed ID: 38728069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults.
    Sjölund S; Larsson M; Olofsson JK; Seubert J; Laukka EJ
    Chem Senses; 2017 May; 42(4):309-318. PubMed ID: 28334095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Parosmia and phantosmia: clinical update].
    Macario S; Hsieh JW; Daskalou D; Voruz F; Landis BN
    Rev Med Suisse; 2022 Oct; 18(798):1837-1842. PubMed ID: 36200960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simple Disposable Odor Identification Tests for Predicting SARS-CoV-2 Positivity.
    Ziuzia-Januszewska L; Dobrzyński P; Ślączka K; Ciszek J; Krawiec Ł; Wierzba W; Zaczyński A
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phantosmia with COVID-19 Related Olfactory Dysfunction: Report of Nine Case.
    İşlek A; Balcı MK
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2891-2893. PubMed ID: 33728275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.
    Speth MM; Singer-Cornelius T; Oberle M; Gengler I; Brockmeier SJ; Sedaghat AR
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):114-120. PubMed ID: 32423357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of long-lasting phantosmia: a systematic review.
    Saltagi MZ; Rabbani CC; Ting JY; Higgins TS
    Int Forum Allergy Rhinol; 2018 Jul; 8(7):790-796. PubMed ID: 29485754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts.
    Paderno A; Schreiber A; Grammatica A; Raffetti E; Tomasoni M; Gualtieri T; Taboni S; Zorzi S; Lombardi D; Deganello A; Redaelli De Zinis LO; Maroldi R; Mattavelli D
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):955-962. PubMed ID: 32410386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression Symptoms and Olfactory-related Quality of Life.
    Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA
    Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parosmia and Phantosmia: Managing Quality Disorders.
    Altundag A
    Curr Otorhinolaryngol Rep; 2023; 11(1):19-26. PubMed ID: 36721659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting olfactory dysfunction in COVID-19 patients.
    Prem B; Liu DT; Besser G; Sharma G; Dultinger LE; Hofer SV; Matiasczyk MM; Renner B; Mueller CA
    Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3485-3492. PubMed ID: 34757458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.